Product Images Gabapentin

This text appears to show results from a study on pain management, with a chart displaying mean pain scores during the titration and fixed dose periods for a placebo group and a group taking 3600mg/day of Gabapentin. There is not enough information to provide a more detailed description or context for the study.*

This is a table representing the mean pain score for a clinical trial study. The study had two different periods, a dose titration period, and a fixed-dose period. Four different treatments were evaluated, including a placebo group and two Gabapentin treatment groups with daily doses of 1800 and 2400 mg/day. The baseline pain score was also recorded, and pain scores were measured weekly.*

The given text can be seen as a figure showing the proportion of responders in controlled PHN studies. The figure shows pain score reduction percentages from 10% to 100% in increments of 10%. However, without context, it is not possible to determine what the percentages represent. The figure includes the names of different studies, and different values are associated with each study. There are also some numerical values for GBP (pounds). It seems like there may be some statistical analysis involved, as there is some sort of comparison with a p-value.*